European Journal of Surgical Oncology
Volume 33 , Pages S64-S75 , December 2007

Ablative and catheter-delivered therapies for colorectal liver metastases (CRLM)

,Accepted 26 September 2007.

References 

  1. Population screening for colorectal cancer. Drug Ther Bull. 2006;44(9):65–68
  2. McLoughlin JM, Jensen EH, Malafa M. Resection of colorectal liver metastases: current perspectives. Cancer Control. 2006;13(1):32–41
  3. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13(5):668–676
  4. Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–726
  5. Kornprat P, Jarnagin WR, Gonen M, et al. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol. 2007;14(3):1151–1160
  6. Hamady ZZ, Malik HZ, Finch R, et al. Hepatic resection for colorectal metastasis: impact of tumour size. Ann Surg Oncol. 2006;13(11):1493–1499
  7. Pawlik TM, Abdalla EK, Ellis LM, Vauthey JN, Curley SA. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 2006;10(2):240–248
  8. Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg. 2002;137(10):1187–1192
  9. Trerotola SO. Science to practice: can combination therapy for colorectal liver metastases improve results over chemoembolization or ablation alone?. Radiology. 2005;237(2):381–382
  10. Figueras J, Burdio F, Ramos E, et al. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol. 2007;
  11. Wray CJ, Lowy AM, Mathews JB, et al. The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol. 2005;12(5):374–380
  12. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol. 2006;32(5):557–563
  13. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241(5):715–722[discussion 722–724]
  14. Jain S, Sacchi M, Vrachnos P, Lygidakis NJ, Andriopoulou E. Recent advances in the treatment of colorectal liver metastases. Hepatogastroenterology. 2005;52(65):1567–1584
  15. Vogl TJ, Straub R, Zangos S, Mack MG, Eichler K. MR-guided laser-induced thermotherapy (LITT) of liver tumours: experimental and clinical data. Int J Hyperthermia. 2004;20(7):713–724
  16. Yarmenitis SD, Karantanas A, Bakantaki A, Papantoniou Y, Gourtsoyiannis N. Detection of colorectal cancer hepatic metastases with contrast-enhanced ultrasound: comparison with conventional B-mode ultrasound. Dig Dis. 2007;25(1):86–93
  17. Jung EM, Clevert DA, Rupp N. Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors. Rofo. 2003;175(10):1403–1412
  18. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent – early experience. Radiology. 1999;211(3):643–649
  19. Cioni D, Lencioni R, Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound. 2001;13(2):73–93
  20. Silverman PM. Liver metastases: imaging considerations for protocol development with multislice CT (MSCT). Cancer Imaging. 2006;6:175–181
  21. Das M, Sauer F, Schoepf UJ, et al. Augmented reality visualization for CT-guided interventions: system description, feasibility, and initial evaluation in an abdominal phantom. Radiology. 2006;240(1):230–235
  22. Nicolau SA, Pennec X, Soler L, Ayache N. A complete augmented reality guidance system for liver punctures: first clinical evaluation. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv. 2005;8(Pt 1):539–547
  23. Breen MS, Lazebnik RS, Nour SG, Lewin JS, Wilson DL. Three-dimensional comparison of interventional MR radiofrequency ablation images with tissue response. Comput Aided Surg. 2004;9(5):185–191
  24. Breen MS, Lazebnik RS, Fitzmaurice M, Nour SG, Lewin JS, Wilson DL. Radiofrequency thermal ablation: correlation of hyperacute MR lesion images with tissue response. J Magn Reson Imaging. 2004;20(3):475–486
  25. Samset E. Temperature mapping of thermal ablation using MRI. Minim Invasive Ther Allied Technol. 2006;15(1):36–41
  26. Samset E, Mala T, Aurdal L, Balasingham I. Intra-operative visualisation of 3D temperature maps and 3D navigation during tissue cryoablation. Comput Med Imaging Graph. 2005;29(6):499–505
  27. Wansapura JP, Daniel BL, Vigen KK, Butts K. In vivo MR thermometry of frozen tissue using R2* and signal intensity. Acad Radiol. 2005;12(9):1080–1084
  28. Fournial R, Traoré AS, Laurendeau D, Moisan C. An analytic method to predict the thermal map of cryosurgery iceballs in MR images. IEEE Trans Med Imaging. 2004;23(1):122–129
  29. Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol. 2005;43(3):458–464
  30. Becker D, Hänsler JM, Strobel D, Hahn EG. Percutaneous ethanol injection and radio-frequency ablation for the treatment of nonresectable colorectal liver metastases – techniques and results. Langenbecks Arch Surg. 1999;384(4):339–343
  31. Giovannini M. Percutaneous alcohol ablation for liver metastasis. Semin Oncol. 2002;29(2):192–195
  32. Giovannini M, Seitz JF. Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients. Cancer. 1994;73(2):294–297
  33. Livraghi T, Vettori C, Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology. 1991;179(3):709–712
  34. Puls R, Hosten N, Stroszczynski C, Kreissig R, Gaffke G, Felix R. Laser-induced thermotherapy (LITT). Use of round and pointed laser applicator systems – initial results. Rofo. 2001;173(3):263–265
  35. Veenendaal LM, de Jager A, Stapper G, Borel Rinkes IH, van Hillegersberg R. Multiple fiber laser-induced thermotherapy for ablation of large intrahepatic tumors. Photomed Laser Surg. 2006;24(1):3–9
  36. Strickland AD, Clegg PJ, Cronin NJ, et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg. 2002;89(8):1003–1007
  37. Kuang M, Lu MD, Xie XY, et al. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna – experimental and clinical studies. Radiology. 2007;242(3):914–924
  38. Rudmik LR, Magliocco AM. Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol. 2005;92(4):347–359
  39. Meyers MO, Watson JC. Angiogenesis and hepatic colorectal metastases. Surg Oncol Clin N Am. 2003;12(1):151–163
  40. Ahmad SA, Berman RS, Ellis LM. Biology of colorectal liver metastases. Surg Oncol Clin N Am. 2003;12(1):135–150
  41. Takeda A, Stoeltzing O, Ahmad SA, et al. Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol. 2002;9(7):610–616
  42. Horton KM, Abrams RA, Fishman EK. Spiral CT of colon cancer: imaging features and role in management. Radiographics. 2000;20(2):419–430
  43. Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT. Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology. 2002;224(2):542–547
  44. Chen CY, Lee RC, Tseng HS, Chiang JH, Hwang JI, Teng MM. Normal and variant anatomy of hepatic arteries: angiographic experience. Zhonghua Yi Xue Za Zhi (Taipei). 1998;61(1):17–23
  45. Hemming AW, Finley RJ, Evans KG, Nelems B, Fradet G. Esophagogastrectomy and the variant left hepatic artery. Ann Thorac Surg. 1992;54(1):166–168
  46. Chung JW, Kim HC, Yoon JH, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol. 2006;7(4):257–266
  47. Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology. 1982;144(3):485–494
  48. Georgiades CS, Hong K, D'Angelo M, Geschwind JF. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol. 2005;16(12):1653–1659
  49. Zangos S, Gille T, Eichler K, et al. Transarterial chemoembolization in hepatocellular carcinomas: technique, indications, results. Radiologe. 2001;41(10):906–914
  50. Marelli L, Stigliano R, Triantos C, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007;30(1):6–25
  51. Sanz-Altamira PM, Spence LD, Huberman MS, et al. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum. 1997;40(7):770–775
  52. Salman HS, Cynamon J, Jagust M, et al. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer. 2002;2(3):173–179
  53. Lang EK, Brown CL. Colorectal metastases to the liver: selective chemoembolization. Radiology. 1993;189(2):417–422
  54. You YT, Changchien CR, Huang JS, Ng KK. Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer. Int J Colorectal Dis. 2006;21(1):33–37
  55. Ganaha F, Sadaoka S, Yamada T. Continuous arterial infusion strategies using implanted ports. Tech Vasc Interv Radiol. 2002;5(3):170–176
  56. Grosso M, Zanon C, Zanon E, et al. The percutaneous placement of intra-arterial catheters with “reservoirs” for subcutaneous infusion. The technic and preliminary results. Radiol Med (Torino). 1997;94(3):226–232
  57. Kuroiwa T, Honda H, Yoshimitsu K, et al. Complications encountered with a transfemorally placed port-catheter system for hepatic artery chemotherapy infusion. Cardiovasc Intervent Radiol. 2001;24(2):90–93
  58. Taylor RR, Tang Y, Gonzalez MV, Stratford PW, Lewis AL. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci. 2007;30(1):7–14
  59. Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys. 1993;27(1):117–123
  60. Welsh JS, Kennedy AS, Thomadsen B. Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S62–S73
  61. Nijsen JF, van het Schip AD, Hennink WE, Rook DW, van Rijk PP, de Klerk JM. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem. 2002;9(1):73–82
  62. Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol. 2006;17(8):1251–1278
  63. Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol. 2006;17(9):1425–1439
  64. Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol. 2006;17(10):1571–1593
  65. Murthy R, Brown DB, Salem R, et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18(4):553–561
  66. Bianchi HF, Albanese EF. The supraduodenal artery. Surg Radiol Anat. 1989;11(1):37–40
  67. Wind P, Chevallier JM, Sarcy JJ, Delmas V, Cugnenc PH. The infrapyloric artery and cephalic pancreatoduodenectomy with pylorus preservation: preliminary study. Surg Radiol Anat. 1994;16(2):165–172
  68. Catalano O, Esposito M, Nunziata A, Siani A. Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdom Imaging. 2000;25(6):607–614
  69. Szyszko T, Al-Nahhas A, Canelo R, et al. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography. Nucl Med Commun. 2007;28(1):15–20
  70. de Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ. FDG–PET in colorectal cancer. Cancer Imaging. 2006;6:S71–S81
  71. Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol. 2006;16(1):80–87
  72. Wiering B, Ruers TJ, Oyen WJ. Role of FDG–PET in the diagnosis and treatment of colorectal liver metastases. Expert Rev Anticancer Ther. 2004;4(4):607–613
  73. Stippel DL, Brochhagen HG, Arenja M, Hunkemöller J, Hölscher AH, Beckurts KT. Variability of size and shape of necrosis induced by radiofrequency ablation in human livers: a volumetric evaluation. Ann Surg Oncol. 2004;11(4):420–425
  74. de Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol. 2002;178(1):53–59
  75. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol. 1998;9(1 Pt 1):101–111
  76. Yamasaki T, Kimura T, Kurokawa F, et al. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol. 2005;40(2):171–178
  77. Hiraki T, Kanazawa S. Hepatic outflow obstruction created by balloon occlusion of the hepatic vein: induced hepatic hemodynamic changes and the therapeutic applications of hepatic venous occlusion with a balloon catheter in interventional radiology. Acta Med Okayama. 2005;59(5):171–178
  78. Nikfarjam M, Muralidharan V, Malcontenti-Wilson C, McLaren W, Christophi C. Impact of blood flow occlusion on liver necrosis following thermal ablation. ANZ J Surg. 2006;76(1ndash2):84–91
  79. Shen P, Fleming S, Westcott C, Challa V. Laparoscopic radiofrequency ablation of the liver in proximity to major vasculature: effect of the Pringle maneuver. J Surg Oncol. 2003;83(1):36–41
  80. Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery. 2002;132(4):605–611[discussion 611–612]
  81. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound. 2001;13(2):149–158
  82. Marchal F, Elias D, Rauch P, et al. Prevention of biliary lesions that may occur during radiofrequency ablation of the liver: study on the pig. Ann Surg. 2006;243(1):82–88
  83. Hong K, Khwaja A, Liapi E, Torbenson MS, Georgiades CS, Geschwind JF. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006;12(8):2563–2567
  84. Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol. 2006;17(8):1335–1343
  85. Aliberti C, Tilli M, Benea G, Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res. 2006;26(5B):3793–3795
  86. McKay A, Dixon E, Taylor M. Current role of radiofrequency ablation for the treatment of colorectal liver metastases. Br J Surg. 2006;93(10):1192–1201
  87. Gillams AR, Lees WR. Radiofrequency ablation of colorectal liver metastases. Abdom Imaging. 2005;30(4):419–426
  88. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003;90(10):1240–1243
  89. Schindera ST, Nelson RC, DeLong DM, Clary B. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. J Vasc Interv Radiol. 2006;17(10):1631–1637
  90. Elias D, De Baere T, Smayra T, Ouellet JF, Roche A, Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg. 2002;89(6):752–756
  91. Elias D, Baton O, Sideris L, et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol. 2005;90(1):36–42
  92. Elias D, Manganas D, Benizri E, et al. The trans-metastasis hepatectomy (through metastases previously ablated with radiofrequency): results of a 13-case study of colorectal cancer. J Surg Oncol. 2006;93(1):8–12
  93. Giantonio BJ, Levy DE, O'dwyer PJ, Meropol NJ, Catalano PJ, Benson AB. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Co-operative Oncology Group study E2200. Ann Oncol. 2006;17(9):1399–1403
  94. Goyle S, Maraveyas A. Chemotherapy for colorectal cancer. Dig Surg. 2005;22(6):401–414
  95. Hurwitz HI, Fehrenbacher L, Hainsworth JD, et al. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol. 2005;23(15):3502–3508
  96. Nikfarjam M, Muralidharan V, Christophi C. Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery. 2006;139(1):73–81
  97. Christophi C, Nikfarjam M, Malcontenti-Wilson C, Muralidharan V. Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy. World J Surg. 2004;28(10):987–994
  98. Pacella CM, Valle D, Bizzarri G, et al. Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: results of a phase II study. Acta Oncol. 2006;45(1):77–83
  99. Seifert JK, Junginger T. Prognostic factors for cryotherapy of colorectal liver metastases. Eur J Surg Oncol. 2004;30(1):34–40
  100. Seifert JK, Junginger T. Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature. Technol Cancer Res Treat. 2004;3(2):151–163
  101. Seifert JK, Springer A, Baier P, Junginger T. Liver resection or cryotherapy for colorectal liver metastases: a prospective case control study. Int J Colorectal Dis. 2005;20(6):507–520
  102. Shono Y, Tabuse K, Tsuji T, et al. Microwave coagulation therapy for unresectable colorectal metastatic liver tumor. Gan To Kagaku Ryoho. 2002;29(6):856–859
  103. Liang P, Dong BW, Yu XL, et al. Evaluation of long-term therapeutic effects of ultrasound-guided percutaneous microwave ablation of liver metastases. Zhonghua Yi Xue Za Zhi. 2006;86(12):806–810
  104. Tanaka K, Shimada H, Nagano Y, Endo I, Sekido H, Togo S. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery. 2006;139(2):263–273
  105. Morita T, Shibata T, Okuyama M, et al. Microwave coagulation therapy for liver metastases from colorectal cancer. Gan To Kagaku Ryoho. 2004;31(5):695–699
  106. Zhang FJ, Wu PH, Zhao M, Gu YK, Zhang L, Tan ZB. Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi. 2005;27(4):248–250
  107. Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ. Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26(11):1626–1628
  108. Kurokohchi K, Hosomi N, Yoshitake A, et al. Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol–lipiodol injection and radiofrequency ablation. Oncol Rep. 2006;16(5):1067–1070
  109. Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y. Combined treatment, TACE and RF ablation, in HCC: preliminary results. Radiol Med (Torino). 2002;104(5–6):412–420
  110. Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93(8):890–895

PII: S0748-7983(07)00549-5

doi: 10.1016/j.ejso.2007.09.027

European Journal of Surgical Oncology
Volume 33 , Pages S64-S75 , December 2007

Article Tools